A drug administered to a patient for treatment, listed in SEER*Rx as a chemotherapeutic, hormonal or immunotherapy agent should be coded under chemotherapy [#1390], hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s) listed in SEER*Rx for that agent. Do not code under the data item, Other Therapy [NAACCR #1420]. Refer to the 2026 SEER manual for more information.
- Drugs (1805)
- Regimen (458)
- Show Entries
| Name | Primary Site |
|---|---|
| BVAM | |
| BVCPP | |
| BVDS | |
| Bevacizumab + IFL | |
| Biochemotherapy | |
| BuCyE | |
| C-TPF | Head and Neck, stomach |
| CAC | Breast, Ovary |
| CAF | Breast |
| CAFP | Breast |
| CAPIRI | Colorectal, Esophagus, Stomach |
| CAPOX | |
| CB | |
| CCAVV | Lung |
| CCNU-OP | Brain |
| CCVV | Lung |
| CCVVP | Lung |
| CEF | Breast |
| CEM | |
| CEPP | |
| CEV | |
| CFAR | |
| CFL | Head and Neck |
| CFM | Breast |
| CFPT |
Home